Maitham A. Khajah
Safat, KU 13110, Kuwait
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
The Non-Peptide MAS-R Agonist AVE0991 Alleviates Colitis Severity in Mice and Exhibits an Additive Effect with Azathioprine.
Journal: International journal of molecular sciences
Published: May 01, 2025
Lactate Is a Major Promotor of Breast Cancer Cell Aggressiveness.
Journal: Cancers
Published: April 29, 2025
Treatment with onion bulb extract both prevents and reverses allergic inflammation in a murine model of asthma.
Journal: Pharmaceutical biology
Published: April 08, 2024
Effect of minocycline, methyl prednisolone, or combination treatment on the colonic bacterial population in a state of colonic inflammation using the murine dextran sulfate sodium model.
Journal: Microbial cell factories
Published: October 30, 2023
The effect of lactate dehydrogenase inhibitors on proliferation, motility and invasion of breast cancer cells in vitro highlights a new role for lactate.
Journal: Molecular medicine reports
Published: July 26, 2023
Minocycline synergizes with corticosteroids in reducing colitis severity in mice via the modulation of pro-inflammatory molecules.
Journal: Frontiers in pharmacology
Published: July 03, 2023
α7 nicotinic acetylcholine receptor interaction with G proteins in breast cancer cell proliferation, motility, and calcium signaling.
Journal: PloS one
Published: May 17, 2023
MicroRNA expression profiling of endocrine sensitive and resistant breast cancer cell lines.
Journal: Biochemistry and biophysics reports
Published: May 31, 2022
Glucose deprivation reduces proliferation and motility, and enhances the anti-proliferative effects of paclitaxel and doxorubicin in breast cell lines in vitro.
Journal: PloS one
Published: February 01, 2022
Lactate Dehydrogenase A or B Knockdown Reduces Lactate Production and Inhibits Breast Cancer Cell Motility in vitro.
Journal: Frontiers in pharmacology
Published: July 25, 2021
The novel piperazino-enaminone JOAB-40 reduced colitis severity in mice via inhibition tumor necrosis factor-α and interleukin-1β.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 28, 2021
Last Updated: 09/26/2026